Andrew S Ishizuka

8PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsNanomaterialsMedical parasitologyPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 25, 2026
Spatiotemporal dynamics of adoptively transferred stem-like CD8+ T cells in the tumor microenvironment following vaccination.

|Feb 26, 2026
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.

Andrew S Ishizuka, Christopher M Garliss, Robert N Goddu

|May 06, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent.

Stacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang

|Nov 03, 2020
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.

Faezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin

|Jul 11, 2019
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.

Stacie K Totsch, Charles Schlappi, Kyung-Don Kang

|Feb 23, 2017
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.

Kirsten E Lyke, Andrew S Ishizuka, Andrea A Berry

Pageof 2

Frequent Collaborators

3 joint publications

Geoffrey M Lynn

3 joint publications

Christopher M Garliss

2 joint publications

Robert A Seder

1 joint publications

Ondrej Vanek